Latest news
Loading news…
Sorrento Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Diego, California, United States Founded 2006 101-250 employees For Profit
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
6
Investments
5
2 exits
Monthly Visits
Available in Pro Contacts
300
Ticker
SRNE
NASDAQ
Patents
175
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- SRNE
- Exchange
- NASDAQ
- IPO date
- Oct 25, 2013
- Raised at IPO
- $30M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Mobile apps
- 1
- Active products
- 17
- Patents granted
- 175
- Trademarks
- 1
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1M
Investor Activity
- Investments
- 5
- Lead investments
- 2
- Portfolio orgs
- 4
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Founded
- 2006
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 2
- News articles
- 228
- HQ
- San Diego, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
- Exit date
- Oct 25, 2013
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 1
- Trend (90d)
- 0
Investments by Sorrento Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Sorrento Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Sorrento Therapeutics
President & Chief Executive Officer
Director, Chief Financial Officer
Manager, SEC Reporting
300
professional contacts at Sorrento Therapeutics
Contact execs at Sorrento Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Sorrento Therapeutics
Loading news…
FAQs about Sorrento Therapeutics
People who checked this page also checked these
Sectors Sorrento Therapeutics invests & acquires in
Browse the full Acquirezy directory.